Arlington Corporation's financial statements (dollars and shares are in millions) are provided here.

Balance Sheets as of December 31
	2019		2018
Assets
Cash and equivalents	$ 15,000		$ 13,000
Accounts receivable	35,000		30,000
Inventories	31,025		29,000
Total current assets	$ 81,025		$ 72,000
Net plant and equipment	50,000		49,000
Total assets	$131,025		$121,000
Liabilities and Equity
Accounts payable	$ 10,600		$ 9,000
Accruals	7,400		6,000
Notes payable	6,200		5,300
Total current liabilities	$ 24,200		$ 20,300
Long-term bonds	20,000		20,000
Total liabilities	$ 44,200		$ 40,300
Common stock (4,000 shares)	60,000		60,000
Retained earnings	26,825		20,700
Common equity	$ 86,825		$ 80,700
Total liabilities and equity	$131,025		$121,000

Income Statement for Year Ending December 31, 2019
Sales	$240,000
Operating costs excluding depreciation and amortization	190,000
EBITDA	$ 50,000
Depreciation & amortization	7,000
EBIT	$ 43,000
Interest	5,350
EBT	$ 37,650
Taxes (25%)	9,412.50
Net income	$ 28,237.50
Dividends paid	22,112.50

Enter your answers in millions. For example, an answer of $25,000,000,000 should be entered as 25,000. Round your answers to the nearest whole number, if necessary.

1. What was net operating working capital for 2018 and 2019? Assume that all cash is excess cash; i.e., this cash is not needed for operating purposes.

   2018	$ million
   2019	$ million

2. What was Arlington's 2019 free cash flow?

   $ million

3. Construct Arlington's 2019 statement of stockholders' equity.